Ortin Global Limited (BOM:539287)

Market Cap	105.79M
Revenue (ttm)	1.74M
Net Income (ttm)	-9.49M
Shares Out	8.13M
EPS (ttm)	-1.16
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,011
Average Volume	2,213
Open	13.79
Previous Close	13.80
Day's Range	13.60 - 13.79
52-Week Range	9.57 - 20.66
Beta	0.27
RSI	40.45
Earnings Date	Feb 11, 2026

About Ortin Global

Ortin Global Limited engages in the manufacture and trading of pharmaceuticals, drugs, and intermediates in India. The company offers various pharmaceutical formulations of tablets, capsules, syrups, and dry powders; formulations, such as anti-diabetics, anti-allergics, anti-anginal and cardiovascular, sedatives and tranquilisers, anti-helmenthetics, analgesics and antipyretics, anti-biotics-quinolones, anti-biotic-pencillins, antifungal, cephalosporins, and macrolides. Its formulations also include chemo therapeutics, antacids and anti-ulceran...

• Industry: Pharmaceutical Preparations
• Founded: 1986
• Employees: 3
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 539287

Financial Performance

In 2024, Ortin Global's revenue was 3.43 million, a decrease of -84.61% compared to the previous year's 22.26 million. Losses were -8.46 million, -89.47% less than in 2023.